Stay updated on ATI-450 Plus MTX in RA Clinical Trial
Sign up to get notified when there's something new on the ATI-450 Plus MTX in RA Clinical Trial page.

Latest updates to the ATI-450 Plus MTX in RA Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference4%
- Check22 days agoChange DetectedPage updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.SummaryDifference0.5%
- Check29 days agoChange Detected- Added a MedlinePlus Genetics topic covering Rheumatoid arthritis, expanding core content related to genetics and a specific disease.SummaryDifference0.3%
- Check36 days agoChange DetectedVersion updated to v3.0.2 with the MedlinePlus Genetics topic 'Rheumatoid arthritis' removed, plus minor UI/metadata removals (Back to Top and v3.0.1 reference).SummaryDifference0.5%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check50 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations in Poland and Czechia, as well as the introduction of new drug categories and terms related to drug safety. Notably, previous location names and terms have been removed, indicating a restructuring of the content.SummaryDifference7%
Stay in the know with updates to ATI-450 Plus MTX in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ATI-450 Plus MTX in RA Clinical Trial page.